Companies / BOC Sciences / Bemarituzumab
BOC Sciences

Bemarituzumab | BOC Sciences

(0) Write Review

Bemarituzumab is a humanized monoclonal antibody that blocks FGFR2b. Bemarituzumab was approved for the treatment of tumors overexpressing FGFR2b.

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

BOC Sciences
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars